Metabolic Syndrome Does Not Improve the Prediction of 5-Year Cardiovascular Disease and Total Mortality Over Standard Risk Markers. Prospective Population Based Study

摘要

Metabolic syndrome (MS) is widely believed to be an important risk factor for cardiovascular disease (CVD). We assessed whether a model based on MS improved prediction of CVD and total mortality over the Framingham's general CVD system (FRS) and whether MS was better than its individual components.